HIV-1 MN NO Fragment

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Online Inquiry

CAT# Product Name M.W Molecular Formula Inquiry
H09738 HIV - 1 MN #1986 2228.6 Inquiry
H09746 HIV - 1 MN #1990 2240.6 Inquiry
H09750 HIV - 1 MN #1993 2244.5 Inquiry
H09753 HIV - 1 MN #2019 2248.7 Inquiry
H09757 HIV - 1 MN #1987 2260.6 Inquiry
H09761 HIV - 1 MN #1930 2261.8 Inquiry
H09768 HIV - 1 MN #1964 2270.5 Inquiry
H09774 HIV - 1 MN #1963 2278.5 Inquiry
H09777 HIV - 1 MN #2048 2284.7 Inquiry
H09782 HIV - 1 MN #2015 2298.8 Inquiry
H09803 HIV - 1 MN #2007 2346.8 Inquiry
H09804 HIV - 1 MN #2013 2348.8 Inquiry
H09808 HIV - 1 MN #1935 2362.7 Inquiry
H09811 HIV - 1 MN #1922 2370.7 Inquiry
H09813 HIV - 1 MN #2021 2378.8 Inquiry
H09815 HIV - 1 MN #1985 2384.8 Inquiry
H09816 HIV - 1 MN #2022 2385.9 Inquiry
H09820 HIV - 1 MN #2029 2395.6 Inquiry
H09821 HIV - 1 MN #1929 2399.8 Inquiry
H09826 HIV - 1 MN #1988 2409.8 Inquiry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 DAPTA (D-[Ala]-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-amide), D-Ala-Peptide T amide, is one of analogue of peptide T, which ...

 Peptide YY is referred to as PYY. Its structure is highly homologous with pancreatic polypeptide (PP) and neurop ...

 The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...

  APETx2, a 42 amino-acid peptide toxin isolated from sea anemone Anthopleura elegantissima, is a kind of acid-s ...

 Galanin-(2–13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide (M871) is a novel peptide antagonist selectively recognizing ...

Quick Inquiry
×
Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.